Clin Res Cardiol (2021)
DOI DOI https://doi.org/10.1007/s00392-021-01843-w

Chronic Kidney Disease impairs Prognosis in Electrical Storm
K. J. Weidner1, M. Behnes1, T. Schupp1, J. Hoppner2, J. Müller1, M. Borggrefe1, S. Lindner1, D. Ellguth1, M. Akin3, D. Große Meininghaus4, T. Bertsch5, G. Taton1, A. Bollow1, T. Reichelt1, N. Engelke1, L. Reiser1, U. Ansari1, I. Akin1
1I. Medizinische Klinik, Universitätsklinikum Mannheim, Mannheim; 2Universitätsklinikum Heidelberg, Heidelberg; 3Kardiologie und Angiologie, Medizinische Hochschule Hannover, Hannover; 41. Medizinische Klinik, Kardiologie, Angiologie, Carl-Thiem-Klinikum Cottbus gGmbH, Cottbus; 5Institut für klinische Chemie und Laboratoriumsmedizin und Transfusionsmedizin, Klinikum Nürnberg Nord, Nürnberg;


Objectives: 
The study sought to assess the prognostic impact of chronic kidney disease (CKD) in patients with electrical storm (ES). 
Background: ES represents a serious life-threatening heart rhythm disorder. Especially CKD-patients are at risk to suffer from ES. However, data regarding the prognostic impact of CKD on long-term mortality in ES-patients is limited. 
Methods: All consecutive ES-patients with implantable cardioverter defibrillator (ICD) were included retrospectively from 2002 to 2016. Patients with CKD (MDRD-GFR < 60 ml/min/1.73m2) were compared to patients without CKD. The primary endpoint was all-cause mortality at 3 years. Secondary endpoints were in-hospital mortality, cardiac rehospitalization, recurrences of electrical storm (ES-R) and major adverse cardiac events (MACE) at 3 years. 
Results: A total of 70 consecutive ES patients were included. CKD was present in 43% of ES-patients with a median glomerular filtration rate (GFR) of 43.3 ml/min/1.73m2CKD was associated with increased all-cause mortality at 3 years (63% vs. 20%; p=0.001; HR=4.293; 95% CI 1.874-9.836; p=0.00) and MACE (57% vs. 30%; p=0.025; HR=3.597; 95% CI 1.679-7.708; p=0.001). In contrast, first cardiac rehospitalization (43% vs. 45%; log rank p=0.889) and ES-R (30% vs. 20%; log rank p=0.334) were not affected by CKD. Increased long-term mortality was still evident after multivariable adjustment (HR=2.397; 95% CI 1.012-5.697; p=0.047). The presence of CKD was also associated with the secondary endpoint MACE (HR= 2.520; 95% CI 1.109 – 5.727; p= 0.027 after multivariable adjustment.
Conclusion: The presence of CKD was associated with increased long-term mortality and MACE in patients presenting with ES. 


https://dgk.org/kongress_programme/jt2021/aP745.html